Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells

Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

(2019) Jiani Wang et al.   Molecular Therapy-Oncolytics

Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease

(2019) Hengameh Chloé Mirsepasi-Lauridsen et al.   CLINICAL MICROBIOLOGY REVIEWS

Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease

(2019) John Gubatan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Vitamin D in inflammatory bowel disease

(2018) John Gubatan et al.   CURRENT OPINION IN GASTROENTEROLOGY

Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis

(2018) John Gubatan et al.   CYTOKINE

The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance

(2018) Teizo Yoshimura et al.   JOURNAL OF IMMUNOLOGY

Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study

(2016) Toufic A Kabbani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients

(2016) MohammadJavad Hosseinzadeh-Attar et al.   Saudi Journal of Gastroenterology

Cathelicidin Antimicrobial Peptide: A Novel Regulator of Islet Function, Islet Regeneration, and Selected Gut Bacteria

(2015) Lynley D. Pound et al.   DIABETES

Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study

(2015) Tara Raftery et al.   United European Gastroenterology Journal

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

(2013) Weicheng Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Vitamin D Regulates the Gut Microbiome and Protects Mice from Dextran Sodium Sulfate–Induced Colitis

(2013) Jot Hui Ooi et al.   JOURNAL OF NUTRITION

The antimicrobial peptide cathelicidin modulatesClostridium difficile-associated colitis and toxin A-mediated enteritis in mice

(2012) Tressia C Hing et al.   GUT

Associations Between Vitamin D Receptor Polymorphisms and Susceptibility to Ulcerative Colitis and Crohnʼs Disease

(2012) Le-Ning Xue et al.   INFLAMMATORY BOWEL DISEASES

Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis

(2012) Clover Ching Man Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease

(2012) Milan Chromek et al.   PLoS One

Investigating Intestinal Inflammation in DSS-induced Model of IBD

(2012) Janice J. Kim et al.   Jove-Journal of Visualized Experiments

Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice

(2011) Hon Wai Koon et al.   GASTROENTEROLOGY

Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder

(2010) Olof Hertting et al.   PLoS One

The vitamin D–antimicrobial peptide pathway and its role in protection against infection

(2009) Adrian F Gombart   Future Microbiology

Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier

(2007) Juan Kong et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY